The Effect of PEG Use Education on the Care Burden and Quality of Life of Patients' Relatives
The Effect of Discharge Education on PEG Use Given to Palliative Care Patients' Relatives on the Care Burden and Quality of Life of Patients' Relatives
1 other identifier
interventional
62
1 country
1
Brief Summary
The study was planned to evaluate the effects of discharge training on PEG use given to palliative care patients' relatives on the caregiver burden and quality of life of the relatives. The main questions that the study aims to answer are as follows:
- How does PEG training given before discharge affect the knowledge level of caregivers on PEG use?
- How does PEG training given before discharge affect the caregiver burden?
- How does PEG training given before discharge affect the caregiver's caregiver stress?
- How does PEG training given before discharge affect the quality of life of the caregivers? The researchers will compare the PEG training given before discharge with a control group that did not receive training in this regard in order to evaluate the effects of PEG training given before discharge on the caregiver burden, caregiver stress and quality of life of the caregivers. The study will use a general information form, the Caregiver Burden Scale, the Caregiver Stress Index Form, the SF 36 Quality of Life Scale, and the Percutaneous Endoscopic Gastrostomy Tube Nutrition Information Scale for Caregivers. Participants:
- Face-to-face interviews will be conducted with caregivers at 0, 1, and 3 months.
- The forms used in the study will be filled out at each interview.
- The intervention group will be trained only at the first interview.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 6, 2023
CompletedFirst Submitted
Initial submission to the registry
June 15, 2025
CompletedFirst Posted
Study publicly available on registry
July 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2025
CompletedJuly 22, 2025
July 1, 2025
2.3 years
June 15, 2025
July 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Caregiver burden of caregivers
The Caregiver Burden Scale
0th month (1st day), 1st month and 3rd month
The quality of life score of the caregivers
The SF 36 Quality of Life Scale
0th month (1st day), 1st month and 3rd month
Study Arms (2)
Intervention
EXPERIMENTALPEG education
Control
OTHERInterventions
The caregivers will be given a general information form, the Caregiver Burden Scale, the Caregiver Stress Index Form, the SF 36 Quality of Life Scale, and the Caregiver Knowledge Scale for Nutrition with Percutaneous Endoscopic Gastrostomy Tube at each meeting (0, 1, and 3 months.). The intervention group will be trained on PEG use before discharge at the first interview.
The caregivers will be given a general information form, the Caregiver Burden Scale, the Caregiver Stress Index Form, the SF 36 Quality of Life Scale, and the Caregiver Knowledge Scale for Nutrition with Percutaneous Endoscopic Gastrostomy Tube at each meeting (0.,1. ve 3. monts).
Eligibility Criteria
You may qualify if:
- The caregiver must be over 18 years old
- The caregiver must be willing and able to participate in the study
- The caregiver must be primarily responsible for the patient's care
- The patient they are caring for must be receiving palliative care
- The patient they are caring for must be receiving PEG feeding
- The patient they are caring for must be over 18 years old
- The patient they are caring for must have been diagnosed with stroke at least six months ago
- The caregiver must have a mini mental test score of 25 points or more
- The Beck depression scale score must be under 17 points
- The caregiver must have a score of over 16 points on the Readiness to Provide Care Scale
You may not qualify if:
- The caregiver is under the age of 18
- The caregiver is not willing and able to participate in the research
- The caregiver has a physical disability or serious health problem that makes it difficult to provide care
- The patient they are caring for is under the age of 18
- The patient they are caring for has been diagnosed with cancer, endocrine system or GI disease
- The caregiver has a mini mental test score of less than 25
- The Beck depression scale score is 17 points or higher
- The caregiver has scored 16 or lower on the Readiness to Provide Care Scale
- The caregiver has communication problems
- The caregiver has been diagnosed with depression or psychiatric disorder
- The caregiver is receiving psychotherapy/psychological support
- The caregiver is taking antidepressants and/or anxiolytics
- The caregiver has sensory loss related to vision and hearing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Üsküdar State Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hicran Yıldız, Prof.Dr.
Bursa Uludag Unversity
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.Dr.
Study Record Dates
First Submitted
June 15, 2025
First Posted
July 22, 2025
Study Start
July 6, 2023
Primary Completion
October 30, 2025
Study Completion
October 30, 2025
Last Updated
July 22, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Individuals included in the study were informed that the data obtained would be used and published only within the scope of this study, on condition that their identities remained confidential.